← Back to directory

Ladan Fazli

Researcher Next ID · RN-033073

Researcher · Biochemistry, Genetics and Molecular Biology

University of British Columbia

Vancouver, Canada

Accepting doctoral researchersFunding unknown
Works count
799
Citation count
20,252
H-index
80
i10-index
239

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Prostate Cancer Treatment and Research
Cancer, Lipids, and Metabolism
Estrogen and related hormone effects
Heat shock proteins research
Epigenetics and DNA Methylation

Publications

  • Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

    Nature Communications · 2021 · https://doi.org/10.1038/s41467-020-20493-6

  • An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

    Nature Cell Biology · 2021 · https://doi.org/10.1038/s41556-021-00743-5

  • IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

    Nature Communications · 2019 · 10.1038/s41467-018-08152-3

  • ONECUT2 is a driver of neuroendocrine prostate cancer

    Nature Communications · 2019 · https://doi.org/10.1038/s41467-018-08133-6

  • Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer

    European Urology · 2019 · https://doi.org/10.1016/j.eururo.2018.12.042

  • Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts

    Medical Image Analysis · 2018 · 10.1016/j.media.2018.09.005

  • The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

    Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1263

  • Targeting ASCT2 ‐mediated glutamine uptake blocks prostate cancer growth and tumour development

    The Journal of Pathology · 2015 · 10.1002/path.4518

  • Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

    Cancer Cell · 2015 · 10.1016/j.ccell.2015.09.003

  • The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

    Cell Reports · 2015 · https://doi.org/10.1016/j.celrep.2015.07.012

  • High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

    Cancer Research · 2013 · https://doi.org/10.1158/0008-5472.can-13-2921-t

  • Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer

    Cancer Research · 2013 · 10.1158/0008-5472.can-12-3979

  • Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development

    JNCI Journal of the National Cancer Institute · 2013 · 10.1093/jnci/djt241

  • From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

    The Journal of Pathology · 2012 · https://doi.org/10.1002/path.4047

  • The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

    The EMBO Journal · 2011 · 10.1038/emboj.2011.158

  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

    Nature Medicine · 2010 · https://doi.org/10.1038/nm.2236

  • Insulin receptor expression by human prostate cancers

    The Prostate · 2008 · 10.1002/pros.20852

  • Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

    BMC Cancer · 2008 · 10.1186/1471-2407-8-230

  • Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

    Journal of Clinical Pathology · 2007 · 10.1136/jcp.2006.043810

  • Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer

    Cancer Research · 2007 · 10.1158/0008-5472.can-06-3332

  • Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

    Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0703942104

  • Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity

    Cancer Research · 2007 · 10.1158/0008-5472.can-07-2057

  • A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer

    JNCI Journal of the National Cancer Institute · 2005 · 10.1093/jnci/dji252

  • Increased Hsp27 after Androgen Ablation Facilitates Androgen-Independent Progression in Prostate Cancer via Signal Transducers and Activators of Transcription 3–Mediated Suppression of Apoptosis

    Cancer Research · 2005 · 10.1158/0008-5472.can-05-1840

  • Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer

    Cancer Research · 2004 · 10.1158/0008-5472.can-03-3998

  • Regulation of tumor angiogenesis by integrin-linked kinase (ILK)

    Cancer Cell · 2004 · 10.1016/s1535-6108(03)00281-2

Current projects

    No projects listed.